Synthesis and Primary Evaluation of Novel HIV-1 Inhibitors

By Safadi Yazan El   Marquet Roland   Aubertin Anne-Marie   Vivet-Boudou Valérie  

Nucleosides, Nucleotides & Nucleic Acids, Vol. 26, Iss. 8-9, 2007-08 ,pp. : 1161-1165

Taylor & Francis Ltd

Access to resources Recommend Favorite

Novel peptide-based HIV-1 immunotherapy

By Sommerfelt Maja A   Nyhus Jørgen   Sørensen Birger  

Expert Opinion on Biological Therapy, Vol. 4, Iss. 3, 2004-03 ,pp. : 349-361

Informa Healthcare

Access to resources Recommend Favorite

Antiviral Activity of 3-(3,5-Dimethylbenzyl)Uracil Derivatives Against Hiv-1 and HCMV

By Maruyama Tokumi   Demizu Yosuke   Kozai Shigetada   Witvrouw Myriam   Pannecouque Christophe   Balzarini Jan   Snoecks Robert   Andrei Graciella   De Clercq Erik  

Nucleosides, Nucleotides & Nucleic Acids, Vol. 26, Iss. 10-12, 2007-10 ,pp. : 1553-1558

Taylor & Francis Ltd

Access to resources Recommend Favorite

Effectiveness of commercial inhibitors against subtype F HIV-1 protease

By Krauchenco Sandra   Martins Nadia H.   Sanches Mario   Polikarpov Igor  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 24, Iss. 3, 2009-06 ,pp. : 638-645

Informa Healthcare

Access to resources Recommend Favorite

Phosphorothiolate Ribozyme against the Conserved Sequence in V3 Loop of HIV-1

By Zhang X.   Yamada R.   Shimayama T.   Imada K.   Uchiyama T.   Hattori T.  

Biochemical and Biophysical Research Communications, Vol. 229, Iss. 2, 1996-12 ,pp. : 466-471

Elsevier

Access to resources Recommend Favorite